Agenus | AGEN - Ebit


Agenus reported $14.4M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Agenus USD 14.4M 19.26M Dec/2025
Amgen USD 3.83B 130M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Celldex Therapeutics USD -84.44M 2.72M Mar/2026
CSL USD 2.64B 116M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Glaxosmithkline GBP 2.31B 14.92M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
Intrexon USD -26.3M 2.91M Jun/2024
J&J USD 6.62B 1.51B Mar/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
MacroGenics USD -31.88M 19.79M Mar/2026
Merck EUR 1.05B 572M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Northwest Biotherapeutics USD -14.32M 822K Sep/2025
Novartis USD 4.18B 118M Mar/2026
Novavax USD 20.94M 100.32M Dec/2025
Pfizer USD 4.99B 340M Mar/2026
Regeneron Pharmaceuticals USD 744.8M 153.8M Mar/2026
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Veracyte USD 19.08M 5.55M Mar/2026